Skip to content

PathQAS 

PathQASTM iQC schemes are available as a service to customers using our control plasmas and sera. Our current schemes include;

  • PathQAS Coagulation
  • PathQAS Allergy
  • PathQAS Autoimmune
  • PathQAS Calprotectin
  • PathQAS Prekallikrein Activator (PKA)
     

The PathQAS schemes compare test results from specific instruments within a local group, with those of the Peer group, and with the overall values for each test. The PathQAS peer-to-peer iQC schemes aid compliance with the ISO 15189 requirement for inter-laboratory comparisons and the recommendation to use third party controls on a regular basis. 

For further information about our PathQAS schemes, to register or to log into your account, please click the button below 

 

 

 

Latest News


Looking Ahead in ER+/HER2- Breast Cancer - Unpacking Long-Term Prognostic Factors

An interactive discussion shaped by real-world clinical insights!

Subscribe now!

Immunology Manager's Meeting

Eurobio Scientific are going to be at the annual Immunology Manager’s Meeting in Birmingham.

Meet Us At BioMedica!

Endopredict, a NICE-recommended in-vitro diagnostic test for determining the prognosis and treatment response of breast cancer.

The 2024 Emissions Report

As part of our commitment to sustainability, we partner with DHL to cut transport related emissions. Details available in our new 2024 Emissions Report!

Contact Us